相关实验视频

Updated: Jul 17, 2025

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

中国草药治疗伊利诺特干诱导的腹:一个系统的审查和元分析

XiaoLi Lin¹, Yu Fang¹, Yuan Cheng¹

¹Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.

Explore (New York, N.Y.)

|August 28, 2023

概括

中国草药 (CHD) 能够有效地预防伊利诺特干诱导的腹 (IID),这是结直肠癌治疗的常见副作用. 这种补充疗法显示出显著的保护作用,特别是在严重的腹中,副作用最小.

科学领域:

在瘤学瘤学.
胃肠病学胃肠病学
药理学药理学是指药理学的学科.

背景情况:

氨酸是一种一线结直肠癌疗法,具有显著的毒性,特别是腹 (IID).
现有的IID治疗方法往往不令人满意.
中国草药 (CHD) 作为IID的补充和替代疗法正在探索中.

研究的目的:

系统地审查和元分析随机对照试验 (RCT).
评估心脏病对伊利诺特干诱导腹 (IID) 的预防作用.

主要方法:

系统搜索七个数据库的RCT在CHD上用于IID (1980-2022).
进行了偏差风险 (ROB 2.0) 和GRADE评估.
使用RevMan 5.3的元分析,包括子组分析和风险比率 (RR) 和95%置信区间 (CI) 的计算.

主要成果:

14个RCT (1056名参与者) 显示CHD降低了IID发病率 (RR=0.55).
与西方医学 (WM) 结合的CHD比单独的WM更有效 (RR=0.44),特别是在严重的腹 (RR=0.41).
班夏西 (Banxia Xie Xin) 蒸显示出高效率 (RR=0.18);黄 (Huangqin) 蒸得到了广泛的研究 (n=5,RR=0.56). 没有发现任何显著的不良反应.

结论:

冠状动脉病显示出对IID的预防作用.
冠心病可以用作补充疗法,具有良好的安全性.
建议进一步进行大规模,高质量,随机,双盲试验,以获得可靠的临床指导.

关键词:

中国的草药,中国草药.氨酸诱导的腹是因为氨酸.进行元分析分析.

更多相关视频

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

相关概念视频

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...